tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Tianda Pharmaceuticals Reports Significant Revenue Decline and Losses for 2024

Story Highlights
Tianda Pharmaceuticals Reports Significant Revenue Decline and Losses for 2024

TipRanks Cyber Monday Sale

An update from Tianda Pharmaceuticals Ltd. ( (HK:0455) ) is now available.

Tianda Pharmaceuticals Ltd. announced its consolidated financial results for the year ended December 31, 2024, reporting a significant decline in revenue from HK$532,089,000 in 2023 to HK$329,937,000 in 2024. The company experienced a total comprehensive loss of HK$80,686,000, reflecting challenges in sales and increased losses, which may impact its market positioning and stakeholder confidence.

More about Tianda Pharmaceuticals Ltd.

Tianda Pharmaceuticals Ltd. is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry. The company focuses on the development and distribution of pharmaceutical products and services.

YTD Price Performance: 8.24%

Average Trading Volume: 70,130

Technical Sentiment Signal: Buy

Current Market Cap: HK$395.6M

Learn more about 0455 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1